1977Journal of Neurology Neurosurgery & PsychiatryOpen access

Short report: 4-Aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome

Håkan Lundh, Ola Nilsson, I. Rosén

Open full text 111 citations

Abstract

A 67 year old man with the myasthenic syndrome associated with small cell bronchogenic carcinoma was treated with a new drug, 4-aminopyridine. The muscle weakness showed marked improvement and electrophysiological examinations demonstrated restoration of neuromuscular transmission.

Open-access reader

About this research paper

What this paper is about

A 67 year old man with the myasthenic syndrome associated with small cell bronchogenic carcinoma was treated with a new drug, 4-aminopyridine. The muscle weakness showed marked improvement and electrophysiological examinations demonstrated restoration of neuromuscular transmission.

Why it matters

OpenAlex reports 111 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A 67 year old man with the myasthenic syndrome associated with small cell bronchogenic carcinoma was treated with a new drug, 4-aminopyridine. The muscle weakness showed marked improvement and electrophysiological examinations demonstrated restoration of neuromuscular transmission.

Key concepts: Lambert-Eaton myasthenic syndrome, 4-Aminopyridine, Neuromuscular transmission, Medicine, Drug, Weakness, Anesthesia, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Short report: 4-Aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome — Research Paper | ScholarLens